Jon Derricott

@UCeHbriRIjC2pgUPt8HKp0tQ - 4.5K subscribers

A large archive of harm reduction based videos, covering a wide area from heroin to tobacco, with pieces about politics, policy and practice as well. All of them made by me, with the generous help and support of others.

Home Videos Live Playlists

Lessons from HIV campaigns. Professor Mark Nelson

Lessons from HIV campaigns. Professor Mark Nelson Jon Derricott

1.3K views - 7 years ago

Diagnosing the undiagnosed and engaging the disengaged. Dr Andy Ustianowski

Diagnosing the undiagnosed and engaging the disengaged. Dr Andy Ustianowski Jon Derricott

267 views - 7 years ago

Charles Gore: Reflections on 18 years at the Hepatitis C Trust and the future for hepatitis C

Charles Gore: Reflections on 18 years at the Hepatitis C Trust and the future for hepatitis C Jon Derricott

253 views - 7 years ago

LJWG pharmacy testing & treatment overview. Dr Suman Verma

LJWG pharmacy testing & treatment overview. Dr Suman Verma Jon Derricott

248 views - 7 years ago

The LJWG project on the importance of data processes in pathways. Dr Katherine Morely,

The LJWG project on the importance of data processes in pathways. Dr Katherine Morely, Jon Derricott

41 views - 7 years ago

Hepatitis C, Action in London. Susan Hall

Hepatitis C, Action in London. Susan Hall Jon Derricott

190 views - 7 years ago

Economic evaluations of case finding for PWID who have hepatitis C. Professor Peter Vickerman

Economic evaluations of case finding for PWID who have hepatitis C. Professor Peter Vickerman Jon Derricott

270 views - 7 years ago

The changing landscape & the future of hepatitis C treatment. Janet Catt/Chris Laker

The changing landscape & the future of hepatitis C treatment. Janet Catt/Chris Laker Jon Derricott

112 views - 7 years ago

Addressing the health inequalities issue of hepatitis C in London.Dr Yvonne Doyle

Addressing the health inequalities issue of hepatitis C in London.Dr Yvonne Doyle Jon Derricott

334 views - 7 years ago

LJWG Conference 2018. 7 years to HCV elimination: The road to 2025. Stuart Smith

LJWG Conference 2018. 7 years to HCV elimination: The road to 2025. Stuart Smith Jon Derricott

108 views - 7 years ago

The impact of hepatitis C

The impact of hepatitis C Jon Derricott

2.5K views - 7 years ago

There's a footprint to leave: Hepatitis C elimination in London

There's a footprint to leave: Hepatitis C elimination in London Jon Derricott

219 views - 7 years ago

Moving on with my life: Getting cured of hepatitis C

Moving on with my life: Getting cured of hepatitis C Jon Derricott

1.9K views - 7 years ago

GFN Dialogues - Glasgow discussion

GFN Dialogues - Glasgow discussion Jon Derricott

499 views - 8 years ago

GFN Dialogues - Liverpool Discussion

GFN Dialogues - Liverpool Discussion Jon Derricott

1.7K views - 8 years ago

GFN Dialogues - Leicester discussion

GFN Dialogues - Leicester discussion Jon Derricott

613 views - 8 years ago

GFN Dialogues Glasgow, Robbie Preece

GFN Dialogues Glasgow, Robbie Preece Jon Derricott

329 views - 8 years ago

GFN Dialogue Glasgow - Dr Joanna Miler

GFN Dialogue Glasgow - Dr Joanna Miler Jon Derricott

204 views - 8 years ago

GFN Dialogue Glasgow - Andy Morrison

GFN Dialogue Glasgow - Andy Morrison Jon Derricott

139 views - 8 years ago

GFN Dialogue Leicester - Alan Law

GFN Dialogue Leicester - Alan Law Jon Derricott

49 views - 8 years ago

GFN Dialogue Leicester - Louise Ross

GFN Dialogue Leicester - Louise Ross Jon Derricott

80 views - 8 years ago

GFN Dialogue Leicester - Ruth Tennant

GFN Dialogue Leicester - Ruth Tennant Jon Derricott

130 views - 8 years ago

GFN Dialogue Leicester - Dr Konstantinos Farsalinos

GFN Dialogue Leicester - Dr Konstantinos Farsalinos Jon Derricott

515 views - 8 years ago

Tobacco harm reduction roadshow - Leicester, Liverpool & Glasgow

Tobacco harm reduction roadshow - Leicester, Liverpool & Glasgow Jon Derricott

109 views - 8 years ago

Carl Hart - Hit Hot Topics 2016

Carl Hart - Hit Hot Topics 2016 Jon Derricott

883 views - 9 years ago

Users of anabolic steroids and associated drugs. A sentinel population

Users of anabolic steroids and associated drugs. A sentinel population Jon Derricott

851 views - 9 years ago

Introducing multi-agency safety testing to the UK

Introducing multi-agency safety testing to the UK Jon Derricott

351 views - 9 years ago

The Global State of Harm Reduction 2016

The Global State of Harm Reduction 2016 Jon Derricott

163 views - 9 years ago

Q&A Drugs & Race Session HIT Hot Topics 2016

Q&A Drugs & Race Session HIT Hot Topics 2016 Jon Derricott

36 views - 9 years ago

Proportionate policing

Proportionate policing Jon Derricott

196 views - 9 years ago

Race and drugs, the French double blindness

Race and drugs, the French double blindness Jon Derricott

57 views - 9 years ago

From 'other' to 'us'.

From 'other' to 'us'. Jon Derricott

32 views - 9 years ago

Supervised injecting in Scotland? A travel fellowship experience.

Supervised injecting in Scotland? A travel fellowship experience. Jon Derricott

266 views - 9 years ago

Say why to drugs

Say why to drugs Jon Derricott

1.1K views - 9 years ago

Hearing from heroin users

Hearing from heroin users Jon Derricott

296 views - 9 years ago

Sex, drugs and the role of a consultant midwife

Sex, drugs and the role of a consultant midwife Jon Derricott

457 views - 9 years ago

Mat Southwell - drug user organising and the work of EURONPUD

Mat Southwell - drug user organising and the work of EURONPUD Jon Derricott

188 views - 9 years ago

Problematising Hepatitis C Treatment Priorities in England

Problematising Hepatitis C Treatment Priorities in England Jon Derricott

201 views - 9 years ago

The Janus face of drug prohibition: which way are we heading?

The Janus face of drug prohibition: which way are we heading? Jon Derricott

203 views - 9 years ago

GFN 2016: A Swedish perspective on snus

GFN 2016: A Swedish perspective on snus Jon Derricott

1.8K views - 9 years ago

GFN 2016: The e-cigarette environment in Australia

GFN 2016: The e-cigarette environment in Australia Jon Derricott

327 views - 9 years ago

GFN2016: E-cigarettes health potential: current evidence and future areas of exploration

GFN2016: E-cigarettes health potential: current evidence and future areas of exploration Jon Derricott

1.9K views - 9 years ago

GFN2016: 'Not Blowing Smoke' - the fight against misleading messages

GFN2016: 'Not Blowing Smoke' - the fight against misleading messages Jon Derricott

477 views - 9 years ago

GFN2016: Disharmony in the Implementation of the European TPD

GFN2016: Disharmony in the Implementation of the European TPD Jon Derricott

545 views - 9 years ago

GFN2016: Population impacts of snus - tobacco initiation & cessation

GFN2016: Population impacts of snus - tobacco initiation & cessation Jon Derricott

1.1K views - 9 years ago

GFN2016: Lessons for vapers from drugs harm reduction and drug policy reform

GFN2016: Lessons for vapers from drugs harm reduction and drug policy reform Jon Derricott

729 views - 9 years ago

GFN2016: What would good regulation of e-cigarettes look like?

GFN2016: What would good regulation of e-cigarettes look like? Jon Derricott

455 views - 9 years ago

GFN2016: Unacountable and non-transparent: is the FCTC a threat to public health?

GFN2016: Unacountable and non-transparent: is the FCTC a threat to public health? Jon Derricott

281 views - 9 years ago

GFN2016: Population impact of e-cigarettes: recent evidence from the UK

GFN2016: Population impact of e-cigarettes: recent evidence from the UK Jon Derricott

431 views - 9 years ago

GFN2016: Asking the right questions about smoking and alternative nicotine delivery systems

GFN2016: Asking the right questions about smoking and alternative nicotine delivery systems Jon Derricott

715 views - 9 years ago

GFN2016: Prices & e-cigarette demand in the EU

GFN2016: Prices & e-cigarette demand in the EU Jon Derricott

192 views - 9 years ago

GFN2016: Perceptual and experiential factors in switching to e-cigarettes

GFN2016: Perceptual and experiential factors in switching to e-cigarettes Jon Derricott

202 views - 9 years ago

GFN2016: Safety & toxicology of e-cigarettes

GFN2016: Safety & toxicology of e-cigarettes Jon Derricott

2.8K views - 9 years ago

GFN2016: Exhaled aerosol particles e-cigs & cigarettes

GFN2016: Exhaled aerosol particles e-cigs & cigarettes Jon Derricott

478 views - 9 years ago

GFN2016: What I've learned from GFN 2016 - Harry Shapiro

GFN2016: What I've learned from GFN 2016 - Harry Shapiro Jon Derricott

140 views - 9 years ago

GFN2016: E-cigarettes: Gateway or Roadblock to Cigarette Smoking?

GFN2016: E-cigarettes: Gateway or Roadblock to Cigarette Smoking? Jon Derricott

183 views - 9 years ago

GFN2016: Research on electronic cigarettes in Poland

GFN2016: Research on electronic cigarettes in Poland Jon Derricott

226 views - 9 years ago

GFN2016: Tobacco Heating System (THS) 2.2 cardiovascular disease risk assessment

GFN2016: Tobacco Heating System (THS) 2.2 cardiovascular disease risk assessment Jon Derricott

2.7K views - 9 years ago

GFN2016: Compensatory puffing behaviours in e-cigarette users

GFN2016: Compensatory puffing behaviours in e-cigarette users Jon Derricott

340 views - 9 years ago

GFN2016: The power of non-nicotine factors in the habitual use of nicotine products

GFN2016: The power of non-nicotine factors in the habitual use of nicotine products Jon Derricott

860 views - 9 years ago